作者: Ronald G. Victor
关键词: Resistant hypertension 、 Internal medicine 、 Percutaneous 、 Pharmacotherapy 、 Intervention (counseling) 、 Baroreflex 、 Cardiology 、 In patient 、 Medicine
摘要: … In a single-centre, open-label, nonrandomized phase IIa trial, 23 patients with chronic kidney disease (stage ≥3) who received 6 months of baroreflex activation therapy with Barostim …